Merck's Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24% - CNBC

Merck plans to submit the data on early stage lung cancer to the FDA as soon as possible.

Stefanie Joho, 27, stands for a portrait at the home of a friend in Penn Valley, PA on Tuesday, May 9, 2017. Joho, who was diagnosed with colon cancer at 22 years old, has been in remission since Feb… [+4745 chars]

full article...